RNA interference as a potential utility for prostate cancer therapy
Dr Badar A Usmani & Prof Anthony J Turner, School of Biochemistry and Microbiology, University of Leeds

Novel Chemotherapeutic Peptides for Treatment of Prostate Cancer with a New Mode of Action – Targeting the Cell Membrane
Professor Yechiel Shai, Weizmann Institute of Science, Israel

TMF/ARA160 - A Novel Mediator of Androgen Receptor Degradation in Hypoxic prostate carcinoma cells
Professor Uri Nir, Faculty of Life Sciences, Bar-Ilan University , Israel

Finding genes that predispose to prostate cancer: the candidate approach based upon findings in BRCA2
Dr Ros Eeles MA; PhD; FRCP; FRCR, The Institute of Cancer Research

Combined Optical Tweezers and Near IR Spectroscopy for Prostate Cancer Diagnosis
Dr Peter Gardner, The University of Manchester